Medicare Enrolled

Dr. Zaid Jabbar, M.D.

Internal Medicine · Oak Brook, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3011 BUTTERFIELD RD STE 240, Oak Brook, IL 60523
6303483840
In practice since 2008 (18 years)
NPI: 1730351115 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jabbar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jabbar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jabbar

Dr. Zaid Jabbar is an internal medicine specialist in Oak Brook, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Jabbar performed 903 Medicare services across 381 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jabbar received a total of $1,166,739 from 69 pharmaceutical and/or device companies across 3859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jabbar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 39% volume in IL $1,166,739 industry payments

Medicare Practice Summary

Medicare Utilization ↗
903
Medicare services
Top 39% in IL for internal medicine
381
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~50 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
454 $95 $229
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
98 $1 $15
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
92 $11 $62
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
63 $15 $77
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
57 $8 $20
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
53 $29 $152
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
39 $8 $44
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
17 $10 $50
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
16 $13 $69
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
14 $16 $86
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,166,739
Total received (2018-2024)
Avg $166,677/year across 7 years
Top 0% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
3,859
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,129,757 (96.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,649 (1.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,334 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$209,201
2023
$164,435
2022
$181,421
2021
$111,872
2020
$126,078
2019
$206,458
2018
$167,276

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$85,856
AIMMUNE THERAPEUTICS, INC.
$36,214
Novo Nordisk Inc
$33,469
Xeris Pharmaceuticals, Inc.
$17,582
ABBVIE INC.
$14,998
Bayer Healthcare Pharmaceuticals Inc.
$7,846
Currax Pharmaceuticals LLC
$4,722
Esperion Therapeutics, Inc.
$4,345
Medicure Pharma Inc.
$2,500
Boehringer Ingelheim Pharmaceuticals, Inc.
$479
Corcept Therapeutics
$283
AstraZeneca Pharmaceuticals LP
$252
Axsome Therapeutics, Inc.
$194
Amgen Inc.
$157
Otsuka America Pharmaceutical, Inc.
$137
Abbott Laboratories
$76
VIVUS LLC
$42
TheracosBio, LLC
$32
Rhythm Pharmaceuticals, Inc.
$16
Top 3 companies account for 74.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$310,620
Novo Nordisk Inc
$250,362
Boehringer Ingelheim Pharmaceuticals, Inc.
$143,406
Amarin Pharma Inc.
$109,124
Sunovion Pharmaceuticals Inc.
$50,710
Allergan, Inc.
$50,617
ABBVIE INC.
$50,210
AIMMUNE THERAPEUTICS, INC.
$36,214
Bayer HealthCare Pharmaceuticals Inc.
$21,089
AbbVie Inc.
$19,249
Xeris Pharmaceuticals, Inc.
$17,800
Allergan Inc.
$16,670
Currax Pharmaceuticals LLC
$15,169
Takeda Pharmaceuticals U.S.A., Inc.
$13,392
Bayer Healthcare Pharmaceuticals Inc.
$11,941
Esperion Therapeutics, Inc.
$10,434
Medicure Pharma Inc.
$9,750
AstraZeneca Pharmaceuticals LP
$8,172
SANOFI-AVENTIS U.S. LLC
$3,810
Corcept Therapeutics
$2,786
Eli Lilly and Company
$2,209
Janssen Pharmaceuticals, Inc
$1,969
Amgen Inc.
$1,259
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$990
Merck Sharp & Dohme Corporation
$551
Kowa Pharmaceuticals America, Inc.
$477
Antares Pharma, Inc.
$470
Upsher-Smith Laboratories LLC
$462
Teva Pharmaceuticals USA, Inc.
$461
Dexcom, Inc.
$459
Regeneron Healthcare Solutions, Inc.
$381
Regeneron Pharmaceuticals, Inc.
$372
JAZZ PHARMACEUTICALS INC.
$367
Janssen Scientific Affairs, LLC
$350
Endo Pharmaceuticals Inc.
$339
Alfasigma USA, Inc.
$329
Rhythm Pharmaceuticals, Inc.
$292
Shire North American Group Inc
$286
Abbott Laboratories
$249
Medtronic, Inc.
$242
UPSHER-SMITH LABORATORIES LLC
$240
Supernus Pharmaceuticals, Inc.
$235
Axsome Therapeutics, Inc.
$225
Biohaven Pharmaceutical Holding Company Ltd.
$176
VIVUS, Inc.
$161
Otsuka America Pharmaceutical, Inc.
$150
Novartis Pharmaceuticals Corporation
$147
Biohaven Pharmaceuticals, Inc.
$143
Bausch Health US, LLC
$138
PFIZER INC.
$123
EISAI INC.
$117
Eisai Inc.
$108
VIVUS LLC
$103
Merck Sharp & Dohme LLC
$83
ARBOR PHARMACEUTICALS, INC.
$72
Orexigen Therapeutics, Inc.
$58
ITI, Inc.
$57
Acerta Pharma LLC
$55
KVK-Tech, Inc.
$45
Ironwood Pharmaceuticals, Inc
$44
IDORSIA PHARMACEUTICALS US INC
$34
TheracosBio, LLC
$32
Arbor Pharmaceuticals, Inc.
$29
Nalpropion Pharmaceuticals, Inc.
$28
Nalpropion Pharmaceuticals LLC
$26
Astellas Pharma US Inc
$23
Medtronic MiniMed, Inc.
$22
Synergy Pharmaceuticals Inc
$15
West-Ward Pharmaceuticals
$13
Top 3 companies account for 60.4% of all-time payments
Associated products mentioned in payments ›
25208-201-09 · AIMOVIG · AJOVY · APLENZIN · APTIOM · Aggrastat (tirofiban HCl) · Aimovig · Amitiza · Auvelity · BASAGLAR · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BYDUREON · Belviq · Brenzavvy · CAPLYTA · CHANTIX · COMIRNATY · CONTRAVE · CREON · DEXILANT · DIABETES - DISEASE · DUZALLO · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · Entyvio · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · HMG-CoA reductase inhibitor · HMG-CoA reductase inhibitor. · HYPERLIPIDEMIA - DISEASE · IMCIVREE · INVEGA SUSTENNA · INVOKANA · Imcivree · JANUVIA · JARDIANCE · KYNMOBI · Kerendia · Korlym · LATUDA · LINZESS · LONHALA MAGNAIR · LYRICA · Levemir · Linzess · Livalo · MOTEGRITY · MOUNJARO · MYDAYIS · MYRBETRIQ · Mitigare · Motegrity · NASCOBAL · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · ONZETRA XSAIL · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qsymia · RECORLEV · REXULTI · REYVOW · RYBELSUS · ReDS · Repatha · Rybelsus · SIVEXTRO · SOLIQUA · SPIRIVA RESPIMAT · STEGLATRO · STEGLUJAN · SUNOSI · SYMBICORT · SYNJARDY · Saxenda · Sunosi · TLANDO · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · UTIBRON · UTIBRON NEOHALER · Utibron · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZENPEP · ZEPBOUND · ZYPITAMAG · ZYPITAMAG (pitavastatin) · Zelnorm · Zembrace SymTouch Sumatriptan Injection · Zypitamag · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in IL.

Looking for an internal medicine specialist in Oak Brook?
Compare internal medicine physicians in the Oak Brook area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
6,283
Per 100K population
677.6
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jabbar is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of IL peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jabbar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Jabbar performed 454 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jabbar receive payments from pharmaceutical companies?
Yes. Dr. Jabbar received a total of $1,166,739 from 69 companies across 3,859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jabbar's costs compare to other internal medicine physicians in Oak Brook?
Dr. Jabbar's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jabbar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →